OPTOMED — Optomed Oyj Share News
0.000.00%
Last trade - 00:00- €30.19m
- €25.86m
- €17.10m
Brief: Optomed Q1 Revenue Misses Analyst Expectations
Brief: Optomed Posts Negative Q4 EBITDA margin of 8.7%
Brief: Optomed Q4 EBITDA Loss Narrows To EUR 0.3 Mln
Brief: Optomed Completes Directed Share Issue Raising EUR 4.1 Mln
Brief: Optomed Q3 EBITDA Swings TO Profit EUR 0.1 Million
Europe Research Roundup: Go-Ahead, Neste Oyj, Revenio Group Oyj
Brief: Optomed Q2 Adjusted EBITDA Turns To Loss At EUR 0.8 Mln
Brief: Optomed Names Sakari Knuutti As Interim CFO
Brief: Optomed Q1 EBITDA Loss Widens To EUR 937,000
Brief: Optomed Q4 Adjusted EBITDA Loss Widens To EUR 1.5 Mln
Brief: Optomed Announces Clinical Trial Results
Brief: Optomed Q3 Adjusted EBITDA Swings To Loss EUR 337,000
Q1 EBITDA Amounted To EUR -315 Thousand
Brief: Optomed Q4 Adjusted EBITDA Loss Narrows To EUR 62,000
Brief: Optomed Q3 Adjusted EBITDA Swings To Profit Of EUR 229,000
Brief: Optomed Gets Regulatory Approval For Optomed Aurora In China
Brief: Optomed And AEYE Health To Introduce Handheld AI Fundus Camera
Brief: Optomed Adj. EBITDA Swings To Loss Of EUR 325,000
Brief: Optomed Q1 Adjusted EBITDA Swings To Loss EUR 575,000